Home LiteratureArticle Details
PMID: 15140994 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo.

Journal of virology ·Vol. 78 ·No. 11 ·2004-06-00 ·Pages 5966-72

Muruve DA, Cotter MJ, Zaiss AK, White LR, Liu Q, Chan T, Clark SA, Ross PJ, Meulenbroek RA, Maelandsmo GM, Parks RJ

Abstract

Helper-dependent adenovirus (HD-Ad) vectors with all adenoviral genes deleted mediate very long-term expression of therapeutic transgenes in a variety of animal models of disease. These vectors are associated with reduced toxicity and improved safety relative to traditional early region 1 deletion first-generation Ad (FG-Ad) vectors. Many studies have clearly demonstrated that FG-Ad vectors induce innate and adaptive immune responses in vivo; however, a comprehensive analysis of host immune responses to HD-Ad vectors has not yet been performed. In DBA/2 mice, intravenous injection of HD-Ad vectors encoding LacZ (HD-AdLacZ) or a murine secreted alkaline phosphatase (HD-AdSEAP) induced an early expression of inflammatory cytokine and chemokine genes in the liver, including interferon-inducible protein 10, macrophage inflammatory protein 2, and tumor necrosis factor alpha, and were expressed in a pattern similar to that induced by FG-Ad vectors encoding AdSEAP. Like AdSEAP, and consistent with the pattern of cellular gene expression, HD-AdLacZ and HD-AdSEAP induced the recruitment of CD11b-positive leukocytes to the transduced liver within hours of administration. AdSEAP also induced a second phase of liver inflammation, consisting of inflammatory gene expression and CD3-positive lymphocytic infiltrates 7 days posttransduction. In contrast, beyond 24 h no infiltrates or expression of inflammatory genes was detected in the livers of mice receiving HD-AdSEAP. Despite the lack of liver inflammation at 7 days, Ad-specific cytotoxic T lymphocytes could be detected in mice receiving HD-AdSEAP. This lack of liver inflammation was not due to reduced transduction since levels of transgene expression and the amounts of vector DNA in the liver were equivalent in mice receiving HD-AdSEAP and AdSEAP. These results demonstrate that HD-Ad vectors induce intact innate but attenuated adaptive immune responses in vivo.

MeSH Terms
Adenoviridae/immunology Animals Defective Viruses/immunology Genetic Vectors/immunology Immunity, Innate Mice Mice, Inbred DBA Transduction, Genetic Transgenes
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Muruve Daniel A
Faculty of Medicine, University of Calgary, 3330 Hospital Dr. N.W., Calgary, AB, T2N 4N1 Canada. [email protected]
Cotter Matthew J
Zaiss Anne K
White Lindsay R
Liu Qiang
Chan Trevor
Clark Sharon A
Ross P Joel
Meulenbroek Robert A
Maelandsmo Gunhild M
Parks Robin J
References (36)
36 references, click to expand
  1. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.
    Mol Ther. 2001 May;3(5 Pt 1):708-22 PMID: 11356076
  2. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors.
    Hum Gene Ther. 1999 Jul 20;10(11):1773-81 PMID: 10446917
  3. Prolonged transgene expression mediated by a helper-dependent adenoviral vector (hdAd) in the central nervous system.
    Mol Ther. 2000 Aug;2(2):105-13 PMID: 10947937
  4. Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain.
    Mol Ther. 2001 Jan;3(1):36-46 PMID: 11162309
  5. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages.
    Mol Ther. 2001 May;3(5 Pt 1):697-707 PMID: 11356075
  6. Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination.
    Nat Biotechnol. 2001 Jun;19(6):582-5 PMID: 11385466
  7. Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector.
    Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13282-7 PMID: 11687662
  8. Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B.
    Hum Gene Ther. 2002 Feb 10;13(3):367-79 PMID: 11860704
  9. Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system.
    J Virol. 2002 May;76(9):4181-9 PMID: 11932383
  10. Effect of promoters and enhancers on expression, transgene DNA persistence, and hepatotoxicity after adenoviral gene transfer of human apolipoprotein A-I.
    Hum Gene Ther. 2002 May 1;13(7):829-40 PMID: 11975849
  11. Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy.
    Curr Gene Ther. 2002 May;2(2):111-33 PMID: 12109210
  12. Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses.
    J Immunol. 2002 Oct 15;169(8):4651-6 PMID: 12370405
  13. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
    Gene Ther. 2002 Nov;9(22):1520-8 PMID: 12407424
  14. The role of selectins and integrins in adenovirus vector-induced neutrophil recruitment to the liver.
    Eur J Immunol. 2002 Dec;32(12):3443-52 PMID: 12442326
  15. Molecular basis of the inflammatory response to adenovirus vectors.
    Gene Ther. 2003 Jun;10(11):935-40 PMID: 12756413
  16. The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors.
    Hum Gene Ther. 2003 May 1;14(7):627-43 PMID: 12804145
  17. Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates.
    Hum Gene Ther. 2004 Jan;15(1):35-46 PMID: 14965376
  18. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity.
    J Immunol Methods. 1988 Nov 25;115(1):61-9 PMID: 3192948
  19. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.
    J Virol. 1999 Oct;73(10):8027-34 PMID: 10482551
  20. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
    Proc Natl Acad Sci U S A. 1994 May 10;91(10):4407-11 PMID: 8183921
  21. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.
    Immunity. 1994 Aug;1(5):433-42 PMID: 7533647
  22. Pulmonary inflammation induced by incomplete or inactivated adenoviral particles.
    Hum Gene Ther. 1995 Dec;6(12):1553-60 PMID: 8664380
  23. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli.
    J Virol. 1996 Jul;70(7):4805-10 PMID: 8676512
  24. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.
    Gene Ther. 1996 Feb;3(2):137-44 PMID: 8867861
  25. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.
    Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13565-70 PMID: 8942974
  26. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.
    Hum Gene Ther. 1997 Jan 1;8(1):37-44 PMID: 8989993
  27. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging.
    J Virol. 1997 Apr;71(4):3293-8 PMID: 9060698
  28. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.
    Hum Gene Ther. 1997 Jul 1;8(10):1207-17 PMID: 9215738
  29. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.
    Nat Genet. 1998 Feb;18(2):180-3 PMID: 9462752
  30. A simplified system for generating recombinant adenoviruses.
    Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2509-14 PMID: 9482916
  31. Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver.
    J Virol. 1998 Apr;72(4):2945-54 PMID: 9525615
  32. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene.
    Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):7866-71 PMID: 9653106
  33. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.
    Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11377-82 PMID: 9736744
  34. High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity.
    Hum Gene Ther. 1998 Dec 10;9(18):2709-16 PMID: 9874269
  35. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo.
    Hum Gene Ther. 1999 Apr 10;10(6):965-76 PMID: 10223730
  36. Development of a FLP/frt system for generating helper-dependent adenoviral vectors.
    Mol Ther. 2001 May;3(5 Pt 1):809-15 PMID: 11356086
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2004-06-00
Pages
5966-72
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC415814
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]